| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |